Versatility and nuances of the architecture of haematopoiesis - Implications for the nature of leukaemia

Leukemia Research

Volumn 36, Issue 1, 2012, Pages 14-22

  Brown, Geoffrey ^a   Hughes, Philip J ^a   Ceredig, Rhodri ^b   Michell, Robert H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Cell determination; Cell differentiation; Haematopoiesis; Leukaemia

Indexed keywords

AF4 PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; KRUPPEL LIKE FACTOR 4; MIXED LINEAGE LEUKEMIA PROTEIN; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN MYB; RETINOIC ACID RECEPTOR ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR POU; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BLOOD CELL; CANCER CLASSIFICATION; CANCER STEM CELL; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL MATURATION; CELL RENEWAL; CELL TYPE; CHROMOSOME TRANSLOCATION 15; DISEASE COURSE; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOCOMPETENT CELL; LEUKEMIA; LEUKEMOGENESIS; MYELOID LEUKEMIA; NONHUMAN; ONCOGENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVIEW;

CELL DIFFERENTIATION; CELL LINEAGE; COMPREHENSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; MODELS, BIOLOGICAL; NEOPLASTIC STEM CELLS;

EID: 83555176215     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.10.010     Document Type: Review

References (134)

1. Weissman I.L., Anderson D.J., Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol 2001, 17:387-403.
2. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000, 404:193-197.
3. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997, 91:661-672.
4. Graf T. Immunology: blood lines redrawn. Nature 2008, 452:702-703.
5. Ceredig R., Rolink A.G., Brown G. Models of haematopoiesis: seeing the wood for the trees. Nat Rev Immunol 2009, 9:293-300.
6. Brown G., Ceredig R. Lineage determination in haematopoiesis: Quo Vadis. Trends Immunol 2009, 30:465-466.
7. Schlenner S.M., Rodewald H.-R. Early T cell development and the pitfalls of potential. Trends Immunol 2010, 31:303-310.
8. - hematopoietic progenitor with potent lymphoid and myeloid developmental potential. Eur J Immunol 2005, 35:2019-2030.
9. + lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 2005, 121:295-306.
10. Ceredig R., Rauch M., Balciunaite G., Rolink A.G. Increasing FLt3L availability alters composition of a novel bone marrow lymphoid progenitor compartment. Blood 2006, 108:1216-1222.
11. Mercer M., Lin Y.C., Benner C., Jhunjhunwala S., Dutkowmski J., Flores M., et al. Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineage in hematopoietic progenitors. Immunity 2011, 35:1-13.
12. Gauvreau G.M., Ellis A.K., Denburg J.A. Haemopoietic processes in allergic disease: eosinophil/basophil development. Clin Exp Allergy 2009, 39:1297-1306.
13. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R., et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311:83-87.
14. Nozad Charoudeh H.N., Tang Y., Cheng M., Cilio C., Jacobsen S.E.W., Sitnicka E. Identification of an NK/T cell-restricted progenitor in adult bone marrow contributing to bone marrow- and thymic-dependent NK cells. Blood 2010, 116:183-192.
15. Pang L., Weiss M.J., Poncz M. J. Megakaryocyte biology and related disorders. Clin Invest 2005, 115:3332-3338.
16. Bradley T.R., Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci 1966, 44:287-299.
17. Hao Q.L., George A.A., Zhu J., Barsky L., Zielinska E., Wang X., et al. Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7-lympho-myeloid thymic progenitors. Blood 2008, 111:1318-1326.
18. Lawson N.D., Berliner N. Representational difference analysis of a committed myeloid progenitor cell line reveals evidence for bilineage potential. Proc Natl Acad Sci U S A 1998, 95:10129-10133.
19. Komatsu N., Kiroto K., Shimizu M., Kunitama M., Yamada M., Uchida M., et al. In vitro development of erythroid and megakaryocyte cells from a UT-7 subline, UT-7/GM. Blood 1997, 89:4021-4023.
20. Kishi K., Toba K., Azegami T., Tsukada N., Uesugi Y., Masuko M., et al. Hematopoietic cytokine-dependent differentiation to eosinophils and neutrophils in a newly established acute promyelocytic leukaemia cell line with t(15,17). Exp Hematol 1998, 26:135-142.
21. Izon D., Rudd K., DeMuth W., Pear W.S., Clendenin C., Lindsley R.C., et al. A common pathway for dendritic cell and early B cell development. Immunology 2001, 167:1387-1392.
22. Torii I., Morikawa S., Nagasaki M., Nokano A., Morikawa K. Differential endocytic characteristics of a novel human B/DC cell line HBM-Noda: effective macropinocytic and phagocytic function rather than scavenging function. Immunology 2001, 103:70-80.
23. Kharbanda S., Salter R.D., Dong X., Tuma-Warrino R.J., Steinman R.A. BDCM: a novel B-cell line with genetic and functional similarity to dendritic cells. Br J Haematol 2002, 119:819-825.
24. Montecino-Rodriguez E., Leathers H., Dorshkind K. Bipotential B-macrophage progenitors are present in adult bone marrow. Nat Immunol 2001, 2:83-88.
25. Ghinassi B., Sanchez M., Martinelli F., Amabile G., Vannucchi A.M., Migliaccio G., et al. The hypomorphic Gatalow mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor. Blood 2007, 109:1460-1471.
26. Boyd A.W., Schrader J.W. Derivation of macrophage-like lines from the pre-B lymphoma ABLS 8.1 using 5-azacytidine. Nature 1982, 297:691-693.
27. Dy M., Pacilio M., Arnould A., Machavoine F., Mayeux P., Hermine O., et al. Modulation of histidine decarboxylase activity and cytokine synthesis in human cell lines: relationship with basophilic and/or megakaryocytic differentiation. Exp Hematol 1999, 27:1295-1305.
28. Beneytout J.L., Nappez C., Leboutet M.J., Malinvaud G. A plant steroid, diogenein, a new megakaryocytic inducer of HEL cells. Biochem Biophys Res Commun 1995, 207:398-404.
29. Khanna-Gupta A., Kolibaba K., Zibello T.A., Berliner N. NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression. Blood 1994, 84:294-302.
30. Jin J.O., Park H.Y., Kim J.W., Park J.I., Hong Y.S., Min do S., et al. Phosphatidic acid induces the differentiation of human acute promyelocytic leukemic cells into dendritic cell-like. J Cell Biochem 2007, 100:191-203.
31. Guimaraes J.E., Francis G.E., Bol S.J., Berney J.J., Hoffbrand A.V. Differentiation restriction in the neutrophil-granulocyte, macrophage, eosinophil-granulocyte pathway: analysis by equilibrium density centrifugation. Leuk Res 1982, 6:791-800.
32. Paul C.C., Mahrer S., Tolbert M., Elbert B.L., Wong I., Ackermann S.J., et al. Changing the differentiation program of hematopoietic cells, retinoic acid-induced shift of eosiophil-committed cells to neutrophils. Blood 1995, 86:3737-3744.
33. Baumann M.A., Paul C.C. The AML14 and AML14.3D10 cell lines: a long-overdue model for the study of eosinophils and more. Stem Cells 1998, 16:16-24.
34. Yamaguchi Y., Nishio H., Kasahara T., Ackerman S.J., Koyanagi H., Suda T. Models of lineage switching in hematopoietic development: a new myeloid-committed eosinophil cell line (YJ) demonstrates trilineage potential. Leukaemia 1998, 12:1430-1439.
35. Braunstein M., Rajkumar P., Claus C.L., Vaccarelli G., Moore A.J., Wang D., et al. HEBAlt enhances the T-cell potential of fetal myeloid-biased precursors. Int Immunol 2010, 22:963-972.
36. Benne C., Lelievre J.D., Balbo M., Henry A., Sakano S., Levy Y. Notch increases T/NK potential of human hematopoietic progenitors and inhibits B cell differentiation at a pro-B stage. Stem Cells 2009, 27:1676-1685.
37. Ma F., Koike K., Higuchi T., Kinoshita T., Takeuchi K., Mwamtemi H.H., et al. Establishment of a GM-CSF-dependent megakaryoblastic cell line with the potential to differentiate into an eosinophilic lineage in response to retinoic acids. Br J Haematol 1998, 100:427-435.
38. Sato T., Watanabe S., Ishii E., Tsuji K., Nakahata T. Induction of the erythropoietin receptor gene and acquisition of responsiveness to erythropoietin by stem cell factor in HML/SE, a human leukemic cell line. J Biol Chem 1998, 273:16921-16926.
39. Ishikawa F., Niiro H., Iino T., Yoshida S., Saito N., Onohara S., et al. The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. Blood 2007, 110:3591-3660.
40. Doulatov S., Notta F., Eppert K., Nguyen L.T., Ohashi P.S., Dick J.E. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol 2010, 11:585-593.
41. Fisher A.G., Burdet C., LeMeur M., Haasner D., Gerber P., Ceredig R. Lymphoproliferative disorders in an IL-7 transgenic mouse line. Leukaemia 1993, Suppl. 2:S66-S68.
42. Collins S.J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 1987, 70:1233-1244.
43. Hutt-Taylor S.R., Harnish D., Richardson M., Ishizaka T., Denburg J.A. Sodium butyrate and T-lymphocyte cell line-derived differentiation factor induce basophilic differentiation of the human promyelocytic leukaemia cell line HL-60. Blood 1988, 71:209-215.
44. Fabian I., Lass M., Kletter Y., Golde D.W. Differentiation and functional activity of human eosinophilic cells from an eosinophil HL-60 subline: response to recombinant hematopoietic growth factors. Blood 1992, 80:788-794.
45. Fischkoff S.A., Condon M.E. Switch in differentiative response to maturation inducers of human promyelocytic leukaemia cells by prior exposure to alkaline conditions. Cancer Res 1985, 45:2065-2069.
46. Tian F.Q., Zhang L.S., Wang C.Y., Tao W.G. Induction of dendritic cells derived from acute promyelocytic leukemia cells by all trans retinoic acid. Zhongguo Shi Yan Xue Za Zhi 2008, 16:1140-1145.
47. Yamashita M., Ichikawa A., Katakura Y., Mochizuki Y., Teruya K., Kim E.H., et al. Induction of basophilic and eosinophilic differentiation in the human leukaemic cell line KU812. Cytotechnology 2001, 36:179-186.
48. Zein S., Li W., Ramakrishnan V., Lou T.F., Sivanand S., Mackie A., et al. Identification of fetal heamglobin-inducing agents using the human leukaemia KU812 cell line. Exp Biol Med 2010, 235:1385-1394.
49. Isoda H., Kitamoto D.K., Shinmoto H., Matsumura M., Nakahara T. Microbial extracellular glycolipid induction of differentiation and inhibition of protein linase C activity of human promyelocytic leukemia cell line HL60. Biosci Biotech Biochem 1997, 61:609-614.
50. Alitalo R. Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts. Leuk Res 1990, 14:501-514.
51. Kobayashi S., Kimura F., Ikeda T., Osaqa Y., Torikai H., Kobayashi A., et al. BCR-ABL promotes neutrophilic differentiation in the chronic phase of chronic myeloid leukaemia by down-regulating c-Jun expression. Leukemia 2009, 23:1622-1627.
52. Nutt S.L., Heavey B., Rolink A.G., Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999, 401:603-606.
53. Rolink A.G., Schaniel C., Busslinger M., Nutt S.L., Melchers F. Fidelity and infidelity in commitment to B-lymphocyte lineage development. Immunol Rev 2000, 175:104-111.
54. Arinobu Y., Mizuno S., Chong Y., Shigematsu H., Iino T., Iwasaka H., et al. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages. Cell Stem Cell 2007, 11:416-427.
55. Heyworth C.M., Dexter T.M., Kan O., Whetton A. The role of hematopoietic growth factors in self-renewal and differentiation of IL-3-dependent multipotent stem cells. Growth Factors 1990, 2:297-311.
56. Heyworth C., Alaudin M., Cross M., Fairburn L., Dexter M. Erythroid development of the FDCP-MixA4 multipotent cell line is governed by the relative concentrations of erythropoietin and interleukin 3. Br J Haematol 1995, 91:15-22.
57. Schroeder T., Lange C., Strehl J., Just U. Generation of functionally mature dendritic cells from the multipotent stem cell line FDCP-mix. Br J Haematol 2000, 111:890-897.
58. Tsai S., Bartelmez S., Sitnicka E., Collins S. Lymphohematopoietic progenitors immortalized by a retroviral vector harbouring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 1994, 8:2831-2841.
59. Kutlesa S., Zayas J., Valle A., Levy R.B., Jurecic R. T-cell differentiation of multipotent hematopoietic cell line EML in the OP9-DL1 coculture system. Exp Hematol 2009, 37:909-923.
60. Lai A.Y., Kondo M. Asymemetrical lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors. J Exp Med 2006, 203:1867-1873.
61. Ye M., Graf T. Early decisions in lymphoid development. Curr Opin Immunol 2007, 19:123-128.
62. Katsura Y. Redefinition of lymphoid progenitors. Nat Rev Immunol 2002, 2:127-132.
63. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007, 7:19-30.
64. Richie Ehrlich L.I., Serwood T., Weissman I.L. In vitro assays misrepresent in vivo lineage potentials of murine lymphoid progenitors. Blood 2011, 117:2618-2624.
65. Crooks G.M. Lineage assays: which pathways to take?. Blood 2011, 117:2560.
66. Porritt H.E., Rumfelt L.L., Tabrizifard S., Scmitt T.M., Zuniga-Pflucker J.C., Petrie H.T. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cells and non-T cell lineages. Immunity 2004, 20:735-745.
67. Benz C., Bleul C.C. A multipotent progenitor in the thymus maps to the branching point of the T versus B lineage decision. J Exp Med 2005, 202:21-31.
68. Balciunaite G., Ceredig R., Rolink A.G. The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer but no B-lymphocyte potential. Blood 2005, 105:1930-1936.
69. Sambandam A., Maillard I., Zediak V.P., Xu L., Gerstein R.M., Aster J.C., et al. Notch signalling controls the generation and differentiation of early T lineage progenitors. Nat Immunol 2005, 6:663-670.
70. Wilson A., MacDonald H.R., Radtke F. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med 2001, 194:1003-1012.
71. Tan J.B., Visan I., Yuan J.S., Guidos C.J. Requirement for Notch 1 signals at sequential early stages of intra thymic T cell development. Nat Immunol 2005, 6:671-679.
72. Pui J.C., Allman D., Xu L., DeRocco S., Karnell F.G., Bakkour S., et al. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 1999, 11:299-308.
73. Li J., Barreda D.R., Zhang Y.A., Boshra H., Gelman A.E., Lapatra S., et al. B lymphocytes from early vertebrates have potent phagocytic and microbiocidal abilities. Nat Immunol 2006, 7:1116-1124.
74. Painter M.W., Davis S., Hardy R.R., Mathis D., Benoist C. Transcriptome profiles of the B and T lineages compared by multiplatform microarray profiling. J Immunol 2011, 186:3047-3057. The Immunological Genome Project Consortium.
75. Spangrude G.J., Heimfeld S., Weissman I.L. Purification and characterization of mouse hematopoietic stem cells. Science 1988, 241:87-93.
76. Okada S., Nakauchi H., Nagayoshi K., Nishikawa S., Miura Y., Suda T. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood 1992, 80:3044-3050.
77. Challen G.A., Boles N.C., Chambers S.M., Goodell M.A. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-β1. Cell Stem Cell 2010, 6:265-278.
78. Beerman I., Bhattacharya D., Zandi S., Sigvardsson M., Weissman I.L., Bryder D., et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci U S A 2010, 107:5465-5470.
79. Morita Y., Ema H., Nakauchi H. Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J Exp Med 2010, 207:1173-1182.
80. Cavazzana-Calvo M., Payen E., Negre O., Wang G., Hehir K., Fusil F., et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 2010, 467:318-322.
81. Cavazzana-Calvo M., Fischer A., Bushman F.D., Payen E., Hacein-Bey-Abina S., Leboulch P. Is normal hematopoiesis maintained solely by long-term multipotent stem cells?. Blood 2011, 117:4420-4424.
82. Greaves M. Cancer stem cells: back to Darwin. Semin Cancer Biol 2010, 20:65-70.
83. Kawamoto H., Katsura Y. A new paradigm for hematopoietic cell lineages: revision of the classical concept of the myeloid-lymphoid dichotomy. Trends Immunol 2009, 30:193-200.
84. Brown G., Hughes P.J., Michell R.H., Rolink A., Ceredig R. The sequential determination model of hematopoiesis. Trends Immunol 2007, 28:442-448.
85. Novershtern N., Subramanian A., Lawton L.N., Mak R.H., Haining W.N., McConkey M.E., et al. Densely interconnected transcription circuits control cell states in human hematopoiesis. Cell 2011, 144:296-309.
86. Brown G., Hughes P.J., Michell R.H., Ceredig R. The versatility of haematopoietic stem cells: implications for leukaemia. Crit Rev Clin Lab Sci 2010, 47:171-180.
87. Kawamoto H., Ohmara K., Katsura Y. Direct evidence for the commitment of hematopoietic stem cells to T, B, and myeloid lineages in murine fetal liver. Int Immunol 1997, 9:1011-1019.
88. Kawamoto H., Ohmura K., Fujimoto S., Katsura Y. Emergence of T cell progenitors without B cell or myeloid differentiation potential at the earliest stage of hematopoiesis in the murine fetal liver. J Immunol 1999, 2725-2731.
89. Kawamoto H., Ikawa T., Ohmura K., Fujimoto S., Karsura Y. T cells progenitors emerge earlier than B cell progenitors in the murine fetal liver. Immnuity 2000, 12:441-450.
90. Kawamoto H., Ikawa T., Masuda K., Wada H., Katsura Y. A map for lineage restriction of progenitors during hematopoiesis: the essence of the myeloid-based model. Immunol Rev 2010, 238:23-36.
91. Katsura Y., Kawamoto H. Stepwise lineage restriction of progenitors in lympho-myelopoiesis. Int Rev Immunol 2001, 20:1-20.
92. Lane S.W., Gilliand D.G. Leukaemia stem cells. Semin Cancer Biol 2010, 20:71-76.
93. Buzzai M., Licht J.D. New molecular concepts and targets in acute myeloid leukaemia. Curr Opin Hematol 2008, 15:82-87.
94. Krause D.S., Van Etten R.A. Right on: eradicating leukaemic stem cells. Trends Mol Med 2007, 13:470-481.
95. Bonnet D., Dick J.E. Human acute myeloid leukaemia is organised as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737.
96. Lapidot T., Sirard C., Vormoor J., Murdock B., Hoang T., Caceres-Cortes J., et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
97. Shultz L.D., Pearson T., King M., Giassi L., Carney L., Gott B., et al. Humanised nOD/LtSz-scid IL2 receptor common gamma chain knock-out mice in diabetes research. Ann N Y Acad Sci 2007, 1103:77-89.
98. Goardon N., Marchi E., Atzberger A., Quek L., Schuh A., Soneji S., et al. Coexistence of LMPP-like and GMP-like leukaemia stem cells in acute myeloid leukaemia. Cancer Cell 2011, 19:138-152.
99. McDermot S.P., Eppert K., Lechman E.R., Doedens M., Dick J.E. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood 2010, 116:193-200.
100. Diamanti P., Cox C.V., Blair A. Comparison of childhood leukaemia initiating populations in NOD/SCID and NSG mice. Leukemia 2011, 10.1039/leu.2011.212.
101. Krivtsov A.V., Twomey D., Feng Z., Stubbs M.C., Wang Y., Faber J., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006, 442:257-268.
102. Somervaille T.C., Cleary M.L. Identification and characterisation of leukaemia stem cells in murine MLL-AF9 acute myeloid leukaemia. Cancer Cell 2006, 10:257-268.
103. Han Y.C., Park C.Y., Bhagat G., Zhang J., Wang Y., Fan J.B., et al. MicroRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukaemia. J Exp Med 2010, 207:475-489.
104. Matutes E., Morilla R., Carbonell F., Swansbury J., Dyer M., Catovsky D. Definition of acute biphenotypic leukaemia. Haematologica 1997, 82:64-66.
105. Weir E.G., Ali Ansari-Lari M., Batista D.A., Fuller S., Smith B.D., Borowitz M.J. Acute bilineage leukaemia: a rare disease with poor outcome. Leukaemia 2007, 21:2264-2270.
106. Rubnitz J.E., Onciu M., Pounds S., Shurtleff S., Raimondi S.C., Behm F.G., et al. Acute mixed lineage leukaemia in children: the experience of St Jude Children's Research Hospital. Blood 2009, 113:5083-5089.
107. Bene M.C. Biphenotypic, bilineal, ambiguous or mixed lineage: strange leukaemias!. Haematologica 2009, 94:891-893.
108. Smith L.J., Curtis J.E., Messner H.A., Senn J.S., Furthmayr H., McCulloch E.A. Lineage infidelity in acute leukaemia. Blood 1983, 61:1138-1145.
109. Greaves M.F., Chan L.C., Furley A.J., Watt S.M., Molgaard H.V. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 1986, 67:1-11.
110. Davey F.R., Abraham N., Brunetto V.L., MacCallum J.M., Nelson D.A., Ball E.D., et al. Morphological characteristics of erythroleukemia (acute myeloid leukemia, FAB_M6). Am J Hematol 1995, 49:29-38.
111. Kowal-Vern A., Mazzella F.M., Cotelingham J.D., Shrit M.A., Rector J.T., Schumacher H.R. Diagnosis and characterisation of acute erythroleukaemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases. Am J Hematol 2000, 65:5-13.
112. Grimwade D., Enver T. Acute promyelocytic leukaemia: where does it stem from?. Leukemia 2004, 18:375-384.
113. Edwards R.H., Wasik M.A., Finan J., Rodriguez R., Moore J., Kamoun M., et al. Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia. Am J Clin Pathol 1999, 112:819-827.
114. Guglliel C., Martelli M.P., Diverio D., Fenu S., Vegna M.L., Cantu-Rajnoldi A., et al. Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. Br J Haematol 1998, 102:1035-1041.
115. Chapiro E., Delabesse E., Asnafi V., Millien C., Davi F., Nugent E., et al. Expression of T-lineage-affiliated transcripts and TCR rearrangements in acute promyelocytic leukemia: implications for the cellular target of t(15,17). Blood 2006, 108:3484-3493.
116. Greaves M.F. Differentiation-linked leukemogenesis in lymphocytes. Science 1986, 243:697-704.
117. Greaves M.F. Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 1999, 35:173-185.
118. Cox C.V., Blair A. A primitive cell origin for B-cell precursor ALL?. Stem Cell Rev 2005, 1:189-196.
119. Bueno C., Montes R., Catalina P., Rodriguez R., Mendendez P. Insights into the cellular origin and etiology of the infant pro-B acute leukaemia with MLL-AF4 rearrangement. Leukemia 2011, 25:400-410.
120. Pui C.H. Acute lymphoblastic leukemia in children. Curr Opin Oncol 2000, 12:3-12.
121. Eguchi M., Eguchi-Ishimae M., Greaves M.F. Molecular pathogenesis of MLL-assiciated leukaemias. Int J Hematol 2005, 82:9-20.
122. 19- cells. Cancer Res 2005, 65:1442-1449.
123. Young R. Control of the embryonic stem cell state. Cell 2011, 144:940-954.
124. Yamanaka S., Blau H.M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 2010, 465:704-712.
125. Gaussmann A., Wenger T., Eberle I., Bursen A., Bracharz S., Herr I., et al. Combined effects of the two reciprocal t(4,11) fusion proteins MLL.AF4 and AF4.MLL confer resitence to apoptosis, cell cycling capacity and growth transformation. Oncogene 2007, 26:3352-3363.
126. Eberle I., Pless B., Braun M., Dingermann T., Marschalek R. Transcriptional properties of human NANOG1 and NANOG2 in acute leukaemia cells. Nucleic Acid Res 2010, 38:5349-5384.
127. Bunaciu R.P., Yen A. Activation of the aryl hydrocarbon receptor AhR promotes retinoic acid-induced differentiation of myeloblastic leukaemia cells by restricting expression of the stem cell transcription factor Oct4. Cancer Res 2011, 71:2371-2380.
128. Beroukhim R., Mermel C.H., Porter D., Wei G., Raychaudhuri S., Donovan J., et al. The landscape of somatic copy number alteration across human cancers. Nature 2010, 463:899-905.
129. Rahl P.B., Lin C.Y., Selia A.C., Flynn R.A., McCuine S., Burge C.B., et al. C-Myc regulates transcriptional pause release. Cell 2010, 141:432-445.
130. Yeh J.R., Munson K.M., chao Y.L., Peterson Q.P., Macrae C.A., Peterson R.T. AML1-ETO reprogrammes hematopoietic cell fate by downregulating scl expression. Development 2008, 135:401-410.
131. Dakic A., Wu L., Nutt S.L. Is PU.1 a dosage-sensitive regulator of haematopoietic lineage commitment and leukaemogenesis?. Trends Immunol 2007, 28:108-114.
132. Bonadies N., Foster S.D., Chan W.I., Spensberger D., Dawson M.A., Spooncer E., et al. Genome-wide analysis of transcriptional reprogramming in mouse models of myeloid leukaemia. PLos One 2011, 6:e16330.
133. O'Neil J., Look A.T. Mechanisms of transcriptional factor deregulation in lymphoid cell transformation. Oncogene 2007, 26:6838-6849.
134. Xiao H., Shi J., Luo Y., Tan Y., He J., Xie W., et al. First report of multiple CEBPA mutations contributing to donor origin of leukaemia relapse after allogeneic hematopoietic transplantation. Blood 2011, 117:5257-5260.